AE Wealth Management LLC Has $62.71 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

AE Wealth Management LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 33.6% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 123,133 shares of the healthcare conglomerate’s stock after purchasing an additional 30,995 shares during the period. AE Wealth Management LLC’s holdings in UnitedHealth Group were worth $62,707,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. Aveo Capital Partners LLC lifted its position in UnitedHealth Group by 23.8% during the fourth quarter. Aveo Capital Partners LLC now owns 2,164 shares of the healthcare conglomerate’s stock worth $1,139,000 after acquiring an additional 416 shares during the last quarter. 9258 Wealth Management LLC boosted its stake in UnitedHealth Group by 7.3% in the 4th quarter. 9258 Wealth Management LLC now owns 4,273 shares of the healthcare conglomerate’s stock valued at $2,250,000 after purchasing an additional 290 shares during the period. Gryphon Financial Partners LLC increased its position in UnitedHealth Group by 80.9% during the 4th quarter. Gryphon Financial Partners LLC now owns 6,220 shares of the healthcare conglomerate’s stock worth $3,275,000 after buying an additional 2,782 shares during the period. TrinityPoint Wealth LLC boosted its position in shares of UnitedHealth Group by 102.8% in the fourth quarter. TrinityPoint Wealth LLC now owns 14,774 shares of the healthcare conglomerate’s stock valued at $7,778,000 after acquiring an additional 7,489 shares during the period. Finally, Quest Partners LLC bought a new position in UnitedHealth Group during the fourth quarter worth about $668,000. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

NYSE UNH opened at $577.10 on Friday. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $532.91 billion, a price-to-earnings ratio of 35.28, a PEG ratio of 1.64 and a beta of 0.58. The stock has a fifty day simple moving average of $575.84 and a 200 day simple moving average of $519.83. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $607.94.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 EPS for the quarter, beating analysts’ consensus estimates of $6.66 by $0.14. The business had revenue of $98.86 billion for the quarter, compared to analysts’ expectations of $98.73 billion. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.14 earnings per share. Sell-side analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a dividend of $2.10 per share. The ex-dividend date is Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.46%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on the stock. Wells Fargo & Company increased their target price on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. UBS Group raised their price objective on UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research note on Thursday, July 18th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 target price on shares of UnitedHealth Group in a report on Monday. HSBC boosted their price target on UnitedHealth Group from $580.00 to $610.00 in a research note on Thursday, July 18th. Finally, Royal Bank of Canada raised their target price on shares of UnitedHealth Group from $555.00 to $615.00 and gave the company an “outperform” rating in a report on Wednesday, July 17th. One equities research analyst has rated the stock with a hold rating, nineteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group has an average rating of “Buy” and an average target price of $614.17.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.